JAB-BX102 is a human monoclonal antibody (mAb) that targets NT5E/CD73. It is applicable in research studies involving breast cancer, pancreatic cancer, prostate cancer, and other cancers.
Target:
CD73
* VAT and and shipping costs not included. Errors and price changes excepted
